Companies /Healthcare

Jaguar Animal Health Inc

NASDAQ: JAGX Biotechnology
$2.75
▼ $0.74 (−21.28%) today
Markets closed · 10:07pm ET
Today · % change

Fundamentals

Market Cap
$101,110
P/E Ratio
0.0
Profit Margin
-130.8%
Revenue (TTM)
$27.8M
EPS (TTM)
$1,527.43
52-Week Range
$2 – $1,281
Street Target
$262.50

About Jaguar Health

Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset, specifically chronic debilitating diarrhea. The company is headquartered in San Francisco, California.

JAGX Coverage